Second, the c-MYC sequence-containing plasmid (pMEXr) increased the frequencies of mutations in human osteosarcoma U2OS cells, and transient DHX9 deficiency exacerbated these mutations, which comprised of deletions for the most part. This evidence concerns the gene MYC and osteosarcoma.